Evidence map›Paper›PMID 19859790›Full record

ArticleMolecular and cellular biochemistry2010

c-Jun-NH2 terminal kinase (JNK)-mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1.

Kumuda C Das, Harish Muniyappa

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. JUNB and JUND in Urological Cancers: A Literature Review.Current issues in molecular biology · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Role of Thioredoxin in Age-Related Hypertension.Current hypertension reports · 2018
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Differential gene expressions of the MAPK signaling pathway in enterovirus 71-infected rhabdomyosarcoma cells.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kumuda C DasDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. kdas@uams.edu
Harish Muniyappa
University of Arkansas for Medical Sciences · USUniversity of Arkansas Medical Center · US

Funding

DNA damage signaling in oxygen toxicity in lung cellsR01HL071558 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI DAS, KUMUDA C · 2004 to 2007
$1.1M
NHLBI NIH HHS R01 HL 071558NHLBI NIH HHS R01 HL071558
6 · The paper itself

Abstract

Thioredoxin (Trx) is a small ubiquitous protein, which has been shown to be involved in redox-dependent cellular functions. In this article, we demonstrate that the increased level of Trx induces AP-1 DNA binding in a redox-dependent manner by activating JNK subgroup of MAPKs. The majority of AP-1 DNA binding complex was found to be composed of cJun, JunB, and Fra-1. Increased expression of Trx resulted in phosphorylation of cJun, Jun B, and Fra-1. Further, increased expression of Trx induced the phosphorylation of MKK4 and MKK7 which are upstream kinases of the JNK signaling cascade. In co-transfection studies, AP-1-dependent luciferase reporter vector and pcDNA3-Trx increased luciferase activity demonstrating that increased expression of Trx increases AP-1 transactivation. In addition, dominant-negative JNK kinase (dnJNK/MKK4) or dominant-negative JNK (dnJNK) inhibited Trx-mediated AP-1 transactivation, as well as AP-1 DNA binding. Furthermore, transfection of kinase-dead MEKK1, an initiating kinase of the JNK pathway inhibited Trx-mediated AP-1 transactivation and DNA binding, suggesting that MEKK1 may mediate Trx-induced AP-1 activation. In contrast, wild-type MEKK1 overexpression did not inhibit Trx-mediated AP-1 activation. Taken together, our data demonstrate that increased expression of Trx induces MKK4/MKK7-dependent JNK activation, resulting in enhanced DNA binding, and transactivation of AP-1 transcription factor.

Indexed as

DNAFos-Related Antigen 1Genes, ReporterHumansJNK Mitogen-Activated Protein KinasesLuciferasesMAP Kinase Kinase KinasesPhosphorylationProtein BindingProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junThioredoxinsTranscriptional ActivationTranscription Factor AP-1TransfectionTumor Cells, CulturedDNAFos-Related Antigen 1JNK Mitogen-Activated Protein KinasesLuciferasesMAP Kinase Kinase KinasesProto-Oncogene Proteins c-fosProto-Oncogene Proteins c-junThioredoxinsTranscription Factor AP-1

Identifiers

PMID19859790
OpenAlexW2053964248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.